Publicacions en col·laboració amb investigadors/es de Linköping University (12)

2024

  1. Global cross-sectional survey on neonatal pharmacologic sedation and analgesia practices and pain assessment tools: impact of the sociodemographic index (SDI)

    Pediatric Research

2022

  1. Cancer vaccines: the next immunotherapy frontier

    Nature Cancer, Vol. 3, Núm. 8, pp. 911-926

  2. Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss

    Otology and Neurotology, Vol. 43, Núm. 5, pp. 513-529

  3. Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes

    Diabetes/Metabolism Research and Reviews, Vol. 38, Núm. 3

  4. Intra-lymphatic administration of GAD-alum in type 1 diabetes: long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial)

    Acta Diabetologica, Vol. 59, Núm. 5, pp. 687-696

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients

    Frontiers in Immunology, Vol. 11

2018

  1. Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes

    Journal of Diabetes Research, Vol. 2018

  2. Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. Effect of simultaneous vaccination with H1N1 and GAD-alum on GAD65-induced immune response

    Diabetologia, Vol. 60, Núm. 7, pp. 1276-1283

  2. More on Intralymphatic injection of Autoantigen in Type 1 Diabetes

    New England Journal of Medicine

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1